… subsidy did not lead to higher test uptake, but did increase … in price to increase RDT uptake
was mixed: reducing prices … from household surveys be broken down by treatment source (…

… questions about household demographics and assets, malaria … receiving ACT, suggesting
that price or limited availability may … for the support of the National Malaria Control Programme …

… innovative antimalarial therapies and findings could support … End-users did not consider
costs as the main determinant for … treatment options for multidrug-resistant falciparum malaria. …

… The prevalence of uncomplicated malaria increased every year, … by the government and the
cost of treatment is subsidized. … malaria borne by the household were medical costs, namely, …

… for 61% of households in Uganda between 2007 and 2018. … the use of artemisinin-based
combination therapy (ACT) as … that a combination of subsidies, support interventions and price …

… quality-assured artemisinin combination therapies (QAACTs) … two ways using nationally
representative household survey … received a malaria parasitological test, an antimalarial, and a …

… to increase availability and affordability of antimalarial agents. … to appropriate malaria
treatment is pricing of antimalarial … a subsidized price between $0.005 and $ 0.22 per treatment …

… ACT for future use and sharing among family members is a … Malaria economic costs to “ill-funded”
health systems and … Subsidized ACTs in the private sector: CAPSS MoH-MMV Pilot…

… much more expensive artemisinin combination therapies (ACTs), … Without an ACT subsidy,
overall antimalarial use and the … to an increase in ACT (or other antimalarial) use, particularly …

… subsidies. In addition, it puts both present and future patients at risk; inappropriate treatment
of a non-malaria illness with an antimalarial … . Misuse of artemisinin combination therapies …